• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$6.00 -$0.04 (-0.66%)

REAL-TIME: Last trade at

Arena Pharmaceuticals, Inc.

NASDAQ:ARNA

Jump to this page for:

Related Resources

Stocks with implied volatility below IV index mean; HLF ARNA

5/25/2012 by Theflyonthewall.com

Perception, Opportunity in Volatility - Research & Analysis on Arena Pharmaceuticals, Inc. and DryShips Inc.

5/24/2012 by Marketwire

Equity Research on Most Popular Searches: Arch Coal, El Paso, Cree, Barrick Gold, Arena Pharmaceuticals, and CSX

5/23/2012 by PR Newswire

Institutional Investors Bet On Prolor, Synergy, Arena Pharmaceuticals

5/22/2012 by Seeking Alpha

Arena Pharmaceuticals moves up in early trading, resistance is at $6.60

5/22/2012 by Theflyonthewall.com

Stocks with implied volatility below IV index mean; WMT ARNA

5/22/2012 by Theflyonthewall.com

Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock

5/21/2012 by Genetic Engineering News

Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock

5/21/2012 by PR Newswire

Outlooks for Pfizer, Arena and Onyx Following Busy May

5/21/2012 by TheStreet.com

Biotech Stock Live Chat: ASCO & Obesity

5/17/2012 by TheStreet.com

Stocks with implied volatility below IV index mean; JCP ARNA

5/17/2012 by Theflyonthewall.com

Retail and Europe Spoil the Day: Wednesday’s IP Market Recap

5/16/2012 by InvestorPlace

Arena Pharmaceuticals and PowerShares QQQ Trust Among Most Active Stocks in Pre-Market Today on the Nasdaq

5/16/2012 by Minyanville

Critical Alerts For Research in Motion, Hess, Lions Gate, TRW Automotive, and Arena Pharmaceuticals Released By InvestorsObserver

5/16/2012 by StockWatch

Critical Alerts For Research in Motion, Hess, Lions Gate, TRW Automotive, and Arena Pharmaceuticals Released By InvestorsObserver

5/16/2012 by PR Newswire

Arena Pharmaceuticals (ARNA) Prices 11M Offering at $5.50/Share

5/16/2012 by StreetInsider.com

Arena Pharmaceuticals 11M share Spot Secondary priced at $5.50

5/16/2012 by Theflyonthewall.com

Arena Pharmaceuticals Prices Public Offering of Common Stock

5/16/2012 by PR Newswire

Research Reports for Dow Chemical, Valero Energy, Hartford Financial Services, Arena Pharmaceuticals, CONSOL Energy, and Schlumberger

5/16/2012 by PR Newswire

Hot Biotech Stocks Traded by Hedge Funds in First Quarter

5/16/2012 by TheStreet.com

Stocks with implied volatility below IV index mean; AMZN ARNA

5/16/2012 by Theflyonthewall.com

Stocks with implied volatility movement; PCX ARNA

5/16/2012 by Theflyonthewall.com

Markets Grapple With GM, Greece — Tuesday’s IP Market Recap

5/15/2012 by InvestorPlace

Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock

5/15/2012 by Genetic Engineering News

Arena Pharmaceuticals files to sell common stock, no amount given

5/15/2012 by Theflyonthewall.com

Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock

5/15/2012 by PR Newswire

Arena Pharmaceuticals' shares should 'not be chased', Barron's says

5/15/2012 by Theflyonthewall.com

JPMorgan and Banks’ Blue Day: Monday’s IP Market Recap

5/14/2012 by InvestorPlace

Mulling Arena Pharma's Future With Obesity Drug on Approval Path

5/14/2012 by TheStreet.com

Arena Pharmaceuticals target raised to $10 from $7 at BMO Capital

5/14/2012 by Theflyonthewall.com

Pre-market Movers For May 14 (AVP, YHOO, JPM, FRAN, CHK, GOLF, ARNA, ACOM)

5/14/2012 by RTTNews

Arena and Orexigen Compete to Bring First Weight Loss Drug to Market in Nearly 13 Years

5/14/2012 by Marketwire

Arena Pharmaceuticals: FDA Approval Is Just The Beginning

5/13/2012 by Seeking Alpha

24/7 Wall St. Closing Bell

5/11/2012 by 24/7 Wall Street

Jefferies Upgrades Arena Pharmaceuticals to 'Buy'

5/11/2012 by CNBC Video

JPMorgan's 'Egregious' Mistake

5/11/2012 by CNBC Video

Arena Pharmaceuticals rises 60.4%

5/11/2012 by Theflyonthewall.com

Arena Pharmaceuticals, Inc. and Eisai Inc. Expand Marketing and Supply Agreement for Lorcaserin

5/11/2012 by BioSpace

Arena Pharmaceuticals (ARNA) Comes Off Highs, But Boasts $1B Market Cap

5/11/2012 by StreetInsider.com

Stocks to Watch: J.P. Morgan, McDermott, Arena Pharmaceuticals

5/11/2012 by MarketBeat - The Wall Street Journal
See More Articles...